Published November 6, 2025
| Version v1
Report
Open
IUSM-Purdue TREAT-AD Milestone 2 Target Enabling Package: LYN (LYN proto-oncogene, Src family tyrosine kinase)
Authors/Creators
-
1.
Indiana University School of Medicine
-
2.
Indiana Biosciences Research Institute
-
3.
Purdue University
Contributors
Contact person:
Researcher (2):
-
1.
Indiana University School of Medicine
-
2.
Indiana Biosciences Research Institute
-
3.
Purdue University
Description
A Target Enabling Package focused on LYN as it relates to Alzheimer's disease
Files
LYN_Imatinib_M2_TEP_v1_Submitted.pdf
Files
(2.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:39f324144af1906e681deecb2477c794
|
2.7 MB | Preview Download |
Additional details
Funding
- National Institute on Aging
- U54AG065181